Cellectis (CLLS) EBIT Margin (2015 - 2026)
Cellectis (CLLS) reported EBIT Margin of -449.82% for Q2 2026, down 392.50 percentage points from -57.32% a year earlier and down 14.18 percentage points from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) EBIT Margin (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cellectis' EBIT Margin came in at -98.48%, down 18.17 percentage points year-over-year; for FY2025, it came in at -45.34%, up 98.15 percentage points from FY2024.
- EBIT Margin has a five-year change of +143.05 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -143.49% in FY2024 (+12744.20 pp), -12887.68% in FY2023 (-12419.97 pp), -467.72% in FY2022 (-126.72 pp) and -340.99% in FY2021 (-152.60 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBIT Margin since Q1 2024.
- Year over year, EBIT Margin has now declined in each of the last three quarters, with an average year-over-year change of +2933.00 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q1 2024 (a gain of 16395.39 percentage points); the low point was Q3 2022 (a drop of 15120.56 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -435.64% (Q1 2026), -136.46% (Q4 2025) and 22.86% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Cellectis | 148.50 Mn | -604.89 Mn | - | -449.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -449.82% |
| Mar 31, 2026 | -435.64% |
| Dec 31, 2025 | -136.46% |
| Sep 30, 2025 | 22.86% |
| Jun 30, 2025 | -57.32% |
| Mar 31, 2025 | -133.07% |
| Dec 31, 2024 | -83.99% |
| Sep 30, 2024 | -66.48% |
| Jun 30, 2024 | -213.51% |
| Mar 31, 2024 | -461.44% |
| Dec 31, 2023 | -10,451.94% |
| Sep 30, 2023 | -13,336.13% |
| Jun 30, 2023 | -13,270.22% |
| Mar 31, 2023 | -16,856.83% |
| Dec 31, 2022 | -35.32% |
| Sep 30, 2022 | -15,630.29% |
| Jun 30, 2022 | -2,089.75% |
| Mar 31, 2022 | -1,755.44% |
| Dec 31, 2021 | -239.33% |
| Sep 30, 2021 | -509.72% |
API Access
Cellectis EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();